Global Atherectomy Devices Market Size Study & Forecast, by Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy) and Regional Forecasts 2025-2035

Description

The Global Atherectomy Devices Market, valued at approximately USD 1.04 billion in 2024, is anticipated to accelerate at a remarkable CAGR of 8.10% during the forecast period of 2025-2035. Atherectomy devices, designed to excise or pulverize atherosclerotic plaque within blood vessels, have emerged as indispensable tools in the interventional cardiology and peripheral vascular segments. Their adoption is being propelled by the rising prevalence of cardiovascular diseases worldwide, the escalating geriatric population, and the increasing burden of lifestyle-related risk factors such as diabetes and obesity. Moreover, the push for minimally invasive surgical procedures has reinforced the demand for atherectomy systems, as they help reduce procedural risks, shorten recovery times, and improve long-term patient outcomes.

The accelerating incidence of peripheral artery disease (PAD) has resulted in an unprecedented demand for atherectomy devices across global healthcare settings. According to the American Heart Association, PAD affects more than 200 million people globally, with prevalence rates consistently rising in emerging economies. Growing awareness among physicians and patients about advanced treatment options, coupled with the integration of innovative device technologies such as orbital and laser atherectomy systems, is reshaping the competitive landscape. Furthermore, continuous R&D investments and regulatory approvals for next-generation devices with enhanced precision and safety profiles are paving new opportunities for stakeholders. Nevertheless, the high procedural costs, reimbursement limitations in certain countries, and risks of restenosis remain critical challenges that could hinder market growth if not addressed strategically.

Regionally, North America dominated the market in 2024 and is projected to retain a significant share throughout the forecast period, buoyed by its advanced healthcare infrastructure, early adoption of innovative medical technologies, and the high prevalence of cardiovascular disorders. Europe follows closely, driven by favorable reimbursement frameworks and increasing clinical adoption of minimally invasive procedures across countries like Germany, France, and the UK. Meanwhile, Asia Pacific is anticipated to grow at the fastest pace over the coming years, underpinned by rapid urbanization, rising healthcare expenditure, and government-backed initiatives to strengthen cardiovascular disease management. Emerging economies such as China and India, where cardiovascular disease burden is growing at an alarming rate, are set to become pivotal growth engines, attracting substantial investments from both domestic and global device manufacturers.

Major market players included in this report are:

Medtronic Plc
Boston Scientific Corporation
Avinger Inc.
Cardiovascular Systems Inc.
Abbott Laboratories
Koninklijke Philips N.V.
Terumo Corporation
B. Braun Melsungen AG
Johnson & Johnson (Biosense Webster)
Straub Medical AG
BD (Becton, Dickinson and Company)
AngioDynamics Inc.
Merit Medical Systems Inc.
Olympus Corporation
Cook Medical Inc.

Global Atherectomy Devices Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

Directional Atherectomy
Rotational Atherectomy
Orbital Atherectomy
Laser Atherectomy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Atherectomy Devices Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Atherectomy Devices Market Forces Analysis

3.1. Market Forces Shaping The Global Atherectomy Devices Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of PAD/CAD and aging population elevating procedure volumes
- 3.2.2. Shift toward minimally invasive endovascular therapies and technology upgrades (orbital/laser, image-guided, AI-enabled)
3.3. Restraints
- 3.3.1. High device & procedure costs with reimbursement variability across regions
- 3.3.2. Clinical risks (restenosis, distal embolization) and limited operator training in emerging markets
3.4. Opportunities
- 3.4.1. Expansion in Asia Pacific & Latin America with growing cath-lab capacity and ambulatory surgical centers
- 3.4.2. Product innovation (drug-device combinations, atherectomy + DCB/stent synergy) and robotics/AI-assisted precision

Chapter 4. Global Atherectomy Devices Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Atherectomy Devices Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Global Atherectomy Devices Market Performance - Potential Analysis (2025)
5.3. Directional Atherectomy
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Rotational Atherectomy
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Orbital Atherectomy
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Laser Atherectomy
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Atherectomy Devices Market Size & Forecasts by End-User 2025-2035

6.1. Market Overview
6.2. Global Atherectomy Devices Market Performance - Potential Analysis (2025)
6.3. Hospitals
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Ambulatory Surgical Centers
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Atherectomy Devices Market Size & Forecasts by Region 2025-2035

7.1. Atherectomy Devices Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Atherectomy Devices Market
- 7.3.1. U.S. Atherectomy Devices Market
  - 7.3.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End-User breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Atherectomy Devices Market
  - 7.3.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End-User breakdown size & forecasts, 2025-2035
7.4. Europe Atherectomy Devices Market
- 7.4.1. UK Atherectomy Devices Market
  - 7.4.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End-User breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Atherectomy Devices Market
  - 7.4.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End-User breakdown size & forecasts, 2025-2035
- 7.4.3. France Atherectomy Devices Market
  - 7.4.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End-User breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Atherectomy Devices Market
  - 7.4.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End-User breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Atherectomy Devices Market
  - 7.4.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End-User breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Atherectomy Devices Market
  - 7.4.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End-User breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Atherectomy Devices Market
- 7.5.1. China Atherectomy Devices Market
  - 7.5.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End-User breakdown size & forecasts, 2025-2035
- 7.5.2. India Atherectomy Devices Market
  - 7.5.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End-User breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Atherectomy Devices Market
  - 7.5.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End-User breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Atherectomy Devices Market
  - 7.5.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End-User breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Atherectomy Devices Market
  - 7.5.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End-User breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Atherectomy Devices Market
  - 7.5.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End-User breakdown size & forecasts, 2025-2035
7.6. Latin America Atherectomy Devices Market
- 7.6.1. Brazil Atherectomy Devices Market
  - 7.6.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End-User breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Atherectomy Devices Market
  - 7.6.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End-User breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Atherectomy Devices Market
- 7.7.1. UAE Atherectomy Devices Market
  - 7.7.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End-User breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Atherectomy Devices Market
  - 7.7.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End-User breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Atherectomy Devices Market
  - 7.7.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End-User breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Medtronic Plc
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Boston Scientific Corporation
8.4. Abbott Laboratories
8.5. Koninklijke Philips N.V.
8.6. Terumo Corporation
8.7. Cook Medical Inc.
8.8. Johnson & Johnson (Biosense Webster)
8.9. Cardiovascular Systems Inc.
8.10. BD (Becton, Dickinson and Company)
8.11. AngioDynamics Inc.
8.12. Merit Medical Systems Inc.
8.13. Olympus Corporation
8.14. Straub Medical AG
8.15. Avinger Inc.